Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-103046-4   |   PDF   |   Print   |  
published: 25 Jan 2012 last updated: 27 Jul 2020
General Information
6786-01-0182 (adv. 42010.0182); Summary of the risk assessment of a deliberate release (field trial) of genetically modified pea (Pisum sativum; cultivar: Eiffel) BA11-2, issued by the German Competent Authority
EN
25 Sep 2006
Risk assessment details
  • Garden Pea modified for the expression of a single chain antibody (scFv) in the seed
    | Novoplant GmbH | Production of medical or pharmaceutical compounds (human or animal) (Antibodies and antigens)
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
One field site in Germany, for details refer to the German LMO/GMO location register (https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
construct specific PCR-based method
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1